Reaction mechanism for the highly efficient catalytic decomposition of peroxynitrite by the amphipolar iron(III) corrole 1-Fe

Dalton Transactions : an International Journal of Inorganic Chemistry
Shlomit Avidan-Shlomovich, Zeev Gross

Abstract

The amphipolar iron(III) corrole 1-Fe is one of the most efficient catalysts for the decomposition of peroxynitrite, the toxin involved in numerous diseases. This research focused on the mechanism of that reaction at physiological pH, where peroxynitrite is in equilibrium with its much more reactive conjugated acid, by focusing on the elementary steps involved in the catalytic cycle. Kinetic investigations uncovered the formation of a reaction intermediate in a process that is complete within a few milliseconds (k1 ∼ 3 × 10(7) M(-1) s(-1) at 5 °C, about 7 orders of magnitude larger than the first order rate constant for the non-catalyzed process). Multiple evidence points towards iron-catalyzed homolytic O-O bond cleavage to form nitrogen dioxide and hydroxo- or oxo-iron(iv) corrole. The iron(iv) intermediate was found to decay via multiple pathways that proceed at similar rates (k2 about 10(6) M(-1) s(-1)): reaction with nitrogen dioxide to form nitrate, nitration of the corrole macrocyclic, and dimerization to binuclear iron(iv) corrole. Catalysis in the presence of substrates affects the decay of the iron intermediate by either oxidative nitration (phenolic substrates) or reduction (ascorbate). A large enough excess of ascor...Continue Reading

References

Oct 1, 1995·Free Radical Biology & Medicine·S Goldstein, G Czapski
Jan 1, 1995·Free Radical Biology & Medicine·D BartlettW H Koppenol
Jan 1, 1993·Free Radical Research Communications·R E Huie, S Padmaja
Jan 1, 1996·Free Radical Biology & Medicine·J A EscobarE A Lissi
Jan 1, 1996·Chemical Research in Toxicology·M S RamezanianW H Koppenol
Nov 1, 1996·The American Journal of Physiology·J S Beckman, W H Koppenol
Jan 1, 1997·Nutrition Reviews·B Halliwell
Jan 1, 1997·Free Radical Biology & Medicine·W A PryorG L Squadrito
Sep 1, 1997·Archives of Biochemistry and Biophysics·J N LemercierW A Pryor
Sep 19, 1998·Free Radical Biology & Medicine·G L Squadrito, W A Pryor
Nov 23, 2000·Nature·T Finkel, N J Holbrook
May 24, 2001·Archives of Biochemistry and Biophysics·R Shimanovich, J T Groves
Nov 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S PfeifferB Mayer
Jul 18, 2002·Nature Reviews. Drug Discovery·Daniela SalveminiSalvatore Cuzzocrea
Jun 11, 2003·American Journal of Respiratory and Critical Care Medicine·Vuokko L Kinnula, James D Crapo
Dec 19, 2003·Free Radical Biology & Medicine·Christophe R KurzWillem H Koppenol
Jan 28, 2004·Cellular and Molecular Life Sciences : CMLS·P ChelikaniP C Loewen
Jul 15, 2004·Dalton Transactions : an International Journal of Inorganic Chemistry·Ines Batinić-HaberleIrwin Fridovich
Jul 22, 2004·Bioconjugate Chemistry·Atif MahammedZeev Gross
Dec 22, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Irina G ObrosovaCsaba Szabó
Mar 3, 2005·Journal of the American Chemical Society·Atif Mahammed, Zeev Gross
Mar 24, 2005·The Journal of Pharmacology and Experimental Therapeutics·Galen M PieperCsaba Szabó
May 3, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Joe M McCord, Marvin A Edeas
Jun 9, 2005·Chemical Reviews·Sara GoldsteinGábor Merényi
Jan 18, 2006·Pharmaceutical Research·Hasmik AgadjanianLali K Medina-Kauwe
Jul 11, 2006·The American Journal of Clinical Nutrition·Bente L HalvorsenRune Blomhoff
Jan 24, 2007·Physiological Reviews·Pál PacherLucas Liaudet
Mar 21, 2007·Journal of the American Chemical Society·Katharina DürrIvana Ivanović-Burmazović
May 5, 2007·Angewandte Chemie·Zoya GershmanZeev Gross
Aug 2, 2007·Nature Reviews. Drug Discovery·Csaba SzabóRafael Radi
Jan 9, 2008·Journal of Inorganic Biochemistry·Adi HaberZeev Gross
Jun 24, 2008·The American Journal of Cardiology·Steven R Steinhubl
Jul 9, 2008·Free Radical Research·Ines Batinic-Haberle, Ludmil T Benov
Apr 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hasmik AgadjanianLali K Medina-Kauwe
Sep 23, 2009·Dalton Transactions : an International Journal of Inorganic Chemistry·Meital EckshtainZeev Gross
Jan 26, 2010·Antioxidants & Redox Signaling·Ines Batinić-HaberleIvan Spasojević
Aug 24, 2010·Chemical Communications : Chem Comm·Atif Mahammed, Zeev Gross
Oct 11, 2011·Molecular Pharmaceutics·Jae Youn HwangLali K Medina-Kauwe

❮ Previous
Next ❯

Citations

Feb 23, 2017·Chemical Reviews·Joana F B BarataJosé A S Cavaleiro
Oct 11, 2017·Chemical Reviews·Regina A BagliaDavid P Goldberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.